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Introduction / objectives
For the recent years, our institution had an incidence of
Clostridium difficile associated disease (CDAD) higher
than the provincial rate. This study reviewed the burden
of CDAD in our hospital.
Methods
CSSSRN is a tertiary regional 230-beds acute care, with
only 34 (15%) single rooms with toilet. Cases from April
2009 to March 2011 were retrieved with Nosokos, a web-
base electronic surveillance software used by our Infec-
tion Control Team. Data analysis included demographics,
risk factors, origin of acquisition, isolation, intra-hospital
transfers and complications. The estimated daily costs
per case of CDAD were 1000$/inpatient care, 200$/isola-
tion and enhanced environmental disinfection, 300
$/transfer.
Results
A total of 242 episodes of CDAD in patients were
observed in 190 patients, including 57 (23,4%) recur-
rences. Our incidence rate was 9,6/10000 patients-days.
Many cases were caused by the hyper-virulent strain
NAP1/027. The median age was 75 years (range 2-98)
and 57% were women. The origin of acquisition from
first episodes were nosocomial 60%, transfer from
another facility 9%, non nosocomial 27%, unknown 4%.
Hospitalization was required in 181 episodes (75%) for a
median of 7 days (range 1-167). Colectomy was per-
formed in 5 patients, death < 30 days occurred in 12%
cases . Of 13445 isolation-days, 13,5% were associated
with CDAD, for an average of 1,6 CDAD isolations/100
patients-days. Also, 10357 intra-hospital transfers were
done and 1,3% were CDAD cases. Using our definitions,
the estimated costs of CDAD in our institution were 2
600 000 $ for the 2-year period.
Conclusion
CDAD caused severe disease, in an elderly population,
with a high death rate of 12% and yearly costs of 1 300
000 $ in our institution.
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